Viewing StudyNCT00099580



Ignite Creation Date: 2024-05-05 @ 11:38 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00099580
Status: COMPLETED
Last Update Posted: 2015-01-19
First Post: 2004-12-17

Brief Title: PROCLAIM Effect of AC2592 Administered by Continuous Subcutaneous Infusion in Subjects With Advanced Chronic Congestive Heart Failure
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Congestive Heart Failure
Keywords:
Name View
metabolic abnormality View
Congestive Heart Failure View
AC2592 View
GLP-1 View
Amylin View